Retinal Vein Occlusions Preferred Practice Pattern®

Ophthalmology. 2020 Feb;127(2):P288-P320. doi: 10.1016/j.ophtha.2019.09.029. Epub 2019 Sep 25.

Authors

Christina J Flaxel¹, Ron A Adelman², Steven T Bailey¹, Amani Fawzi³, Jennifer I Lim⁴, G Atma Vemulakonda⁵, Gui-Shuang Ying⁶

Affiliations

¹ Casey Eye Institute, Oregon Health & Science University, Portland, OR.
² Yale University Eye Center, New Haven, CT.
³ Feinberg School of Medicine, Northwestern University, Chicago, IL.
⁴ University of Illinois at Chicago, Chicago, IL.
⁵ Department of Ophthalmology, Palo Alto Medical Foundation, Palo Alto, CA.
⁶ Center for Preventative Ophthalmology and Biostatistics, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

PMID: 31757503
DOI: 10.1016/j.ophtha.2019.09.029

No abstract available

Publication types

Practice Guideline

MeSH terms

Academies and Institutes
Angiogenesis Inhibitors / therapeutic use
Glucocorticoids / therapeutic use
Humans
Laser Coagulation
Ophthalmology / organization & administration
Practice Patterns, Physicians' / standards*
Retinal Vein Occlusion* / diagnosis
Retinal Vein Occlusion* / etiology
Retinal Vein Occlusion* / therapy
Societies, Medical / standards
United States
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Vision Disorders / prevention & control

Substances

Angiogenesis Inhibitors
Glucocorticoids
VEGFA protein, human
Vascular Endothelial Growth Factor A